As diabetes care continues to be a significant focus, innovative treatments are emerging . Retatrutide, Tirzepatide, and Semaglutide represent a remarkable advancement in GLP-1 receptor agonist medications. https://semaglutide782888.bcbloggers.com/42080181/retatrutide-vs-tirzepatid-vs-semaglutide-a-direct-comparison